Mesalamine Tablet, Delayed Release
Product Images NDC 70771-1071

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 70771-1071). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0597b64c Aa1f 42bd 8fc0 49fb44ca0124 02

This is a description of a medication called "Mesalamine". It is available in the form of delayed-release tablets with each tablet containing 12 mg of Mesalamine. The package insert should be consulted for the usual dosage. The tablets should be stored at a temperature between 20 to 25°C and in a light-resistant container as per USP guidelines. The medication should be kept out of the reach of children. The manufacturer of the medication is Zydus.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.